[Prevention of fractures with therapeutic agents for osteoporosis].
Hosoi
Takayuki
T
Endocrinology Section, Tokyo Metropolitan Geriatric Medical Center.
D000368:Aged; D015519:Bone Density; D004164:Diphosphonates / Q000627:therapeutic use*; D020847:Estrogen Receptor Modulators / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy; D005265:Femoral Neck Fractures / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D015201:Meta-Analysis as Topic; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D016103:Spinal Fractures / Q000209:etiology / Q000517:prevention & control*
D004164:Diphosphonates; D020847:Estrogen Receptor Modulators; D020849:Raloxifene Hydrochloride